{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T21:20:30Z","timestamp":1787692830051,"version":"build-2784847793"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004628","name":"AstraZeneca UK Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004628","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014101","name":"Novavax Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cmi.2026.08.001","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T15:14:14Z","timestamp":1786202054000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["id.DRIVE: a public-private partnership for infectious disease surveillance, vaccine research, and pandemic preparedness in Europe and beyond"],"prefix":"10.1016","author":[{"given":"Antonio","family":"Carmona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Gabrielle","family":"Breugelmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Beutels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda Marquina","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Moyersoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Orrico S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Griet","family":"Rebry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena G.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Torcel-Pagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robertus","family":"van Aalst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Praet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Perez Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Rousculp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miloje","family":"Savic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaatje","family":"Bollaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cmi.2026.08.001_bib2","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3390\/ijerph18031058","article-title":"Challenges and adaptation of a European Influenza vaccine effectiveness study platform in response to the COVID-19 emergence: Experience from the DRIVE Project","volume":"18","author":"Carmona","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.cmi.2026.08.001_bib3","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1080\/14760584.2022.2137144","article-title":"The value of public-private collaborative real-world evidence platforms to monitor vaccine performance post authorization: DRIVE - a European initiative","volume":"21","author":"D\u00edez-Domingo","year":"2022","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.cmi.2026.08.001_bib4","article-title":"Protection against COVID-19 hospitalisation conferred by primary-series vaccination with AZD1222 in non-boosted individuals: First vaccine effectiveness results of the European COVIDRIVE study and meta-regression analysis","volume":"31","author":"Meeraus","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.cmi.2026.08.001_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2025.102700","article-title":"Vaccine effectiveness of JCOVDEN single-dose against COVID-19 hospitalisation in Europe: An id.DRIVE test-negative case-control study","volume":"18","author":"Wyndham-Thomas","year":"2025","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.cmi.2026.08.001_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102995","article-title":"Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: A test-negative case-control study using the id.DRIVE platform","volume":"79","author":"Nguyen","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.cmi.2026.08.001_bib7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurpub\/ckae219","article-title":"Effectiveness of the AZD1222 vaccine against COVID-19 hospitalization in Europe: Final results from the COVIDRIVE test-negative case-control study","volume":"35","author":"de Munter","year":"2025","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.cmi.2026.08.001_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0342382","article-title":"Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform","volume":"21","author":"Volkman","year":"2026","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2026.08.001_bib9","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3390\/vaccines13101047","article-title":"Precautionary health behaviours as potential confounders in COVID-19 vaccine effectiveness studies","volume":"13","author":"Wyndham-Thomas","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.cmi.2026.08.001_bib10","doi-asserted-by":"crossref","DOI":"10.1007\/s40121-026-01399-0","article-title":"Viral pathogen-specific severe acute respiratory infections in hospitalised adults in Europe: Epidemiological findings from the id.DRIVE Study 2024-2025","author":"Newell","year":"2026","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.cmi.2026.08.001_bib11","series-title":"Vaccine Monitoring Platform","year":"2022"},{"key":"10.1016\/j.cmi.2026.08.001_bib12","article-title":"Brand-specific influenza vaccine effectiveness in three Nordic countries during the 2024-2025 season: A target trial emulation study based on registry data","volume":"60","author":"Faksova","year":"2026","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.cmi.2026.08.001_bib13","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2025.30.23.2500011","article-title":"Influenza vaccine effectiveness in Europe and the birth cohort effect against influenza A(H1N1)pdm09: VEBIS primary care multicentre study, 2023\/24","volume":"30","author":"Kissling","year":"2025","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cmi.2026.08.001_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/irv.13255","article-title":"Vaccine effectiveness against influenza hospitalisation in adults during the 2022\/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network","volume":"18","author":"Rose","year":"2024","journal-title":"Influenza Other Respir Viruses"},{"issue":"3","key":"10.1016\/j.cmi.2026.08.001_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/irv.70091","article-title":"The global influenza hospital surveillance network: A multicountry public health collaboration","volume":"19","author":"Nunes","year":"2025","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.cmi.2026.08.001_bib16","author":"DARWIN"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26004295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26004295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T21:00:20Z","timestamp":1787691620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X26004295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":15,"alternative-id":["S1198743X26004295"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2026.08.001","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"id.DRIVE: a public-private partnership for infectious disease surveillance, vaccine research, and pandemic preparedness in Europe and beyond","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2026.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}